Pfizer Extends Tender Offer to Buy King Pharmaceuticals for Third Time

Pfizer Inc., the world’s largest drugmaker, extended its tender offer to acquire King Pharmaceuticals Inc. for the third time while the companies await U.S. regulatory approval for the $3.6 billion deal.
Bloomberg